“People will continue to kill themselves, and my patient will continue to suffer in silence until the Victorian Government allows me to access a new treatment which may finally bring peace to a troubled mind,” says Dr. Eli Kotler.
“Our goal is to provide insight on key parameters that may impact and explain the mechanisms behind low-dose treatments,” says MindMed Executive President Dr. Miri Halperin Wernli.
End of content
End of content
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.